Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Comparison of the Effectiveness of EMG-Biofeedback and Rebound Therapy in Patients With Endometriosis

NCT: NCT06517654 · COMPLETED

NCT IDNCT06517654
StatusCOMPLETED
Start Date2024-09-01
Completion2025-11-01

Brief Summary

The aim of our study is to investigate the effects of pelvic floor muscle strengthening exercises with EMG-Biofeedback and pelvic floor muscle strengthening exercises with Rebound therapy on pelvic floor muscle strength, pain level, NGF level, perceived stress level, quality of life and sleep in women diagnosed with endometriosis.

Frequently Asked Questions

What is Comparison of the Effectiveness of EMG-Biofeedback and Rebound Therapy in Patients With Endometriosis?

Comparison of the Effectiveness of EMG-Biofeedback and Rebound Therapy in Patients With Endometriosis is a clinical trial registered under NCT06517654. Current status: COMPLETED.

What is the status of NCT06517654?

The current status of NCT06517654 (Comparison of the Effectiveness of EMG-Biofeedback and Rebound Therapy in Patients With Endometriosis) is: COMPLETED.

When did Comparison of the Effectiveness of EMG-Biofeedback and Rebound Therapy in Patients With Endometriosis start?

Comparison of the Effectiveness of EMG-Biofeedback and Rebound Therapy in Patients With Endometriosis started on 2024-09-01.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑